These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 18560558)
1. Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia. Perfettini JL; Nardacci R; Bourouba M; Subra F; Gros L; Séror C; Manic G; Rosselli F; Amendola A; Masdehors P; Chessa L; Novelli G; Ojcius DM; Siwicki JK; Chechlinska M; Auclair C; Regueiro JR; de Thé H; Gougeon ML; Piacentini M; Kroemer G PLoS One; 2008 Jun; 3(6):e2458. PubMed ID: 18560558 [TBL] [Abstract][Full Text] [Related]
2. Pro-apoptotic function of checkpoint kinase-2 in syncytia elicited by the HIV-1 envelope. Séror C; Raza SQ; Brottes F; Subra F; Piacentini M; Perfettini JL; Kroemer G Cell Cycle; 2009 Feb; 8(3):438-42. PubMed ID: 19177012 [TBL] [Abstract][Full Text] [Related]
3. The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope. Perfettini JL; Nardacci R; Séror C; Bourouba M; Subra F; Gros L; Manic G; Amendola A; Masdehors P; Rosselli F; Ojcius DM; Auclair C; de Thé H; Gougeon ML; Piacentini M; Kroemer G Cell Death Differ; 2009 Feb; 16(2):298-311. PubMed ID: 19023333 [TBL] [Abstract][Full Text] [Related]
4. 53BP1 represses mitotic catastrophe in syncytia elicited by the HIV-1 envelope. Perfettini JL; Nardacci R; Séror C; Raza SQ; Sepe S; Saïdi H; Brottes F; Amendola A; Subra F; Del Nonno F; Chessa L; D'Incecco A; Gougeon ML; Piacentini M; Kroemer G Cell Death Differ; 2010 May; 17(5):811-20. PubMed ID: 19876065 [TBL] [Abstract][Full Text] [Related]
5. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067 [TBL] [Abstract][Full Text] [Related]
6. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137 [TBL] [Abstract][Full Text] [Related]
7. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis. Kurose A; Tanaka T; Huang X; Traganos F; Dai W; Darzynkiewicz Z Cytometry A; 2006 Apr; 69(4):212-21. PubMed ID: 16528719 [TBL] [Abstract][Full Text] [Related]
8. Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. Perfettini JL; Castedo M; Nardacci R; Ciccosanti F; Boya P; Roumier T; Larochette N; Piacentini M; Kroemer G J Exp Med; 2005 Jan; 201(2):279-89. PubMed ID: 15642743 [TBL] [Abstract][Full Text] [Related]
9. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis. Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611 [TBL] [Abstract][Full Text] [Related]
11. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling. Yamauchi M; Oka Y; Yamamoto M; Niimura K; Uchida M; Kodama S; Watanabe M; Sekine I; Yamashita S; Suzuki K DNA Repair (Amst); 2008 Mar; 7(3):405-17. PubMed ID: 18248856 [TBL] [Abstract][Full Text] [Related]
12. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype. Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636 [TBL] [Abstract][Full Text] [Related]
13. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Mochan TA; Venere M; DiTullio RA; Halazonetis TD Cancer Res; 2003 Dec; 63(24):8586-91. PubMed ID: 14695167 [TBL] [Abstract][Full Text] [Related]
14. Histone H2AX participates the DNA damage-induced ATM activation through interaction with NBS1. Kobayashi J; Tauchi H; Chen B; Burma S; Tashiro S; Matsuura S; Tanimoto K; Chen DJ; Komatsu K Biochem Biophys Res Commun; 2009 Mar; 380(4):752-7. PubMed ID: 19338747 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of histone H2AX at M phase in human cells without DNA damage response. Ichijima Y; Sakasai R; Okita N; Asahina K; Mizutani S; Teraoka H Biochem Biophys Res Commun; 2005 Oct; 336(3):807-12. PubMed ID: 16153602 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. Kurz EU; Douglas P; Lees-Miller SP J Biol Chem; 2004 Dec; 279(51):53272-81. PubMed ID: 15489221 [TBL] [Abstract][Full Text] [Related]
17. Aven-dependent activation of ATM following DNA damage. Guo JY; Yamada A; Kajino T; Wu JQ; Tang W; Freel CD; Feng J; Chau BN; Wang MZ; Margolis SS; Yoo HY; Wang XF; Dunphy WG; Irusta PM; Hardwick JM; Kornbluth S Curr Biol; 2008 Jul; 18(13):933-42. PubMed ID: 18571408 [TBL] [Abstract][Full Text] [Related]
18. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Pusapati RV; Rounbehler RJ; Hong S; Powers JT; Yan M; Kiguchi K; McArthur MJ; Wong PK; Johnson DG Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1446-51. PubMed ID: 16432227 [TBL] [Abstract][Full Text] [Related]
19. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity. Cariveau MJ; Tang X; Cui XL; Xu B Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690 [TBL] [Abstract][Full Text] [Related]
20. ATM activation and histone H2AX phosphorylation as indicators of DNA damage by DNA topoisomerase I inhibitor topotecan and during apoptosis. Tanaka T; Kurose A; Huang X; Dai W; Darzynkiewicz Z Cell Prolif; 2006 Feb; 39(1):49-60. PubMed ID: 16426422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]